Typical descriptions: "Day 3 was when I really noticed," "By Thursday (injected Monday) I felt like a different person." Days 4-7: Plateau phase
Neither peptide is a controlled substance under the Misuse of Drugs Act 1971 or current statutory instruments, and supply is permitted on a research-use-only basis
A frequently repeated "half-life ~12.8 days" figure circulates in vendor copy as a rationale for spaced or cyclical dosing
Low Starting Amount Amount per injection: 200 mcg 6 units (0.06 mL) on a U-100 insulin syringe Frequency: Once daily, under the skin (subcutaneous) Cycle length: 812 weeks Inject near the target site or in the abdomen
The combination of peptide therapy and skilled physiotherapy produces results neither approach achieves alone
Your provider reviews your history, medications, goals, and vitals to determine if treatment is appropriate